SEC Form 4 · accession 0001401225-16-000007
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Baljinder Bhullar
Other
Period of report
Apr 29, 2016
Accepted (ET)
Apr 29, 2016 · 10:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 155,375 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.32 | holding | — | — | — | Jul 11, 2011 | Jul 11, 2016 | Common Shares | 110,000 | 110,000 | D |
| Stock Options | $0.09 | holding | — | — | — | Jun 18, 2013 | Jun 18, 2018 | Common Shares | 192,500 | 302,500 | D |
| Stock Options | $0.10 | holding | — | — | — | Dec 23, 2014 | Dec 23, 2019 | Common Shares | 550,000 | 852,500 | D |
Remarks
Effective April, 29, 2016 Baljinder Bhullar has resigned as Chief Financial Officer and Director of Lexaria Corp.